Effect of Miralax NPO Time on Residual Gastric Volumes and Bowel Preparation
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 18
SponsorStanford University
About this trial
The goal of this clinical trial is to assess differences in residual gastric volumes after stopping Miralax ingestion at different time points (1-4 hours) prior to anesthesia induction.
Eligibility criteria
Qualifiers
Patients undergoing both EGD and colonoscopy
Use of Miralax for cleanout
Patients <19 years old
Disqualifiers
Patients with a history of delayed gastric emptying (eg diabetic, GLP-1 intake)
Patients with a history of gastric sleeve surgery
Use of Golytely for cleanout
Emergent EGD/colonoscopies
Trial design
Treatments tested in this trial
- Stopping Miralax ingestion 4 hours prior to anesthesia induction
- Stopping Miralax ingestion 3 hours prior to anesthesia induction
- Stopping Miralax ingestion 2 hours prior to anesthesia induction
- Stopping Miralax ingestion 1 hour prior to anesthesia induction
Treatment groups
200 Participants
are divided into 4 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov